Factors affects the implementation of active surveillance therapy for low-risk papillary thyroid microcarcinoma

  • 0Department of Endocrinology and Metabolism, Institute of Endocrinology, National Health Commission (NHC) Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.

|

|

Summary

No abstract available on PubMed